The announcement, jointly released by the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Finance, the State-owned Assets Supervision and Administration Commission of the State Council, and the State Administration for Market Regulation, highlights Kunming Plasma Products' achievement in intelligent manufacturing by making it to the '2023 Intelligent Manufacturing Demonstration Factories' list. This recognition marks a new milestone in Kunming Plasma Products' efforts towards intelligent manufacturing and digital factory construction.

As a crucial component of China's '14th Five-Year Plan' Intelligent Manufacturing Pilot Demonstration Action, the national-level Intelligent Manufacturing Demonstration Factories and Outstanding Scenes are part of a major national project led jointly by the Ministry of Industry and Information Technology, the National Development and Reform Commission, the State-owned Assets Supervision and Administration Commission of the State Council, the Ministry of Finance, and the State Administration for Market Regulation. The initiative aims to select a group of outstanding intelligent manufacturing scenes and build a set of demonstration factories through a competitive selection process. This project intends to establish leaders in various industries and fields to promote the high-quality development of intelligent manufacturing. The selected enterprises exhibit characteristics such as high degrees of intelligence and digitization, leading technological capabilities, and a strong driving force for industry development.

In both 2017 and 2022, China National Pharmaceutical Group signed a 'Strategic Cooperation Framework Agreement' with the Yunnan provincial government to accelerate the upgrade of Yunnan's biopharmaceutical and healthcare industries. In line with this agreement, China National Pharmaceutical Group's subsidiary, China Biotech, relocated key enterprises from TianTan Bio to Yunnan's Dianzhong New Area, establishing Kunming Plasma Products and supporting single-donor plasma stations within Yunnan. As a demonstration project for 'Central Enterprises Entering Yunnan, Cooperation between Shanghai and Yunnan,' Kunming Plasma Products adheres to PIC/S standards and is constructed strictly in accordance with China's GMP regulations, showcasing advanced technology, leading production capacity in Asia, world-class facilities, and international cutting-edge levels of intelligent manufacturing.

In alignment with the overall deployment of China National Pharmaceutical Group, China Biotech, and TianTan Bio's digital transformation, Kunming Plasma Products is designed and built as a high-standard intelligent manufacturing digital factory. It achieves a comprehensive digital management process, breaking down data barriers by deeply integrating DCS, MES, SCADA, COMOS systems through ITOT networks. Moreover, it seamlessly integrates with ERP, WMS, EMS systems, ensuring a full-process digitalized management from warehousing to production, inspection, quality control, equipment, and energy across the six major aspects. This approach ensures the integrity, reliability, and consistency of data throughout the Plasma Product manufacturing process, promoting refined production management, visualized production decision-making, and significantly enhancing operational efficiency and industry standards.

https://mp.weixin.qq.com/s/N-88IufegoIj6NMOtMN26g